• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血液滤过清除药物。原理及文献数据]

[Elimination of drugs by hemofiltration. Principles and literature data].

作者信息

Hilt H, Keller F

机构信息

Klinik für Anästhesiologie und Operative Intensivmedizin, Klinikum Steglitz der Freien Universität Berlin.

出版信息

Anasth Intensivther Notfallmed. 1987 Dec;22(6):278-82.

PMID:3326424
Abstract

The elimination of substances during hemofiltration depends on the special properties of the used wide-porous membranes. High filtration-fractions are achieved and, in practice, all substances with a molecular weight below 10,000 Dalton pass the membrane. Also drugs are filtrated equivalent to their unbound free plasma-fraction. A quantitative elimination of drugs during hemofiltration is to expect, 1. if a sufficient ultrafiltration rate of 10 ml/min or more is reached, which is the upper limit of spontaneous CAVH, 2. if the sieving-coefficient or plasma-protein-binding enables a sufficient passage and 3. if the serum concentration of the drug related to its administered dose is high, i.e. the volume of distribution is small. An adjustment of drugs is partially necessary during hemofiltration. A simple way is to calculate the total creatinine-clearance to derive dosage modifications.

摘要

血液滤过过程中物质的清除取决于所用大孔膜的特殊性质。可实现高滤过分数,实际上,所有分子量低于10,000道尔顿的物质都能通过膜。药物的滤过与其未结合的游离血浆分数相当。在血液滤过过程中,预计药物能被定量清除,条件如下:1. 达到足够的超滤率,即10毫升/分钟或更高,这是自发性连续性动静脉血液滤过(CAVH)的上限;2. 筛系数或血浆蛋白结合率能使药物充分通过;3. 与给药剂量相关的药物血清浓度较高,即分布容积较小。血液滤过过程中部分药物调整是必要的。一种简单的方法是计算总肌酐清除率以得出剂量调整。

相似文献

1
[Elimination of drugs by hemofiltration. Principles and literature data].[血液滤过清除药物。原理及文献数据]
Anasth Intensivther Notfallmed. 1987 Dec;22(6):278-82.
2
Drug dosing during continuous arteriovenous hemofiltration.持续动静脉血液滤过期间的药物给药
Clin Pharm. 1988 Mar;7(3):198-206.
3
Drug administration in critically ill patients with acute renal failure.急性肾衰竭重症患者的药物给药
New Horiz. 1995 Nov;3(4):748-59.
4
Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations.持续动静脉血液滤过期间的药物清除:理论与临床观察
Int J Artif Organs. 1985 Nov;8(6):307-12.
5
Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.头孢吡肟与连续性肾脏替代治疗(CRRT):两种CRRT膜的体外通透性及4例危重症患者的药代动力学
Clin Ther. 2005 May;27(5):599-608. doi: 10.1016/j.clinthera.2005.05.004.
6
[Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
Anaesthesist. 1989 May;38(5):225-32.
7
Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro.
J Antimicrob Chemother. 2005 Aug;56(2):360-4. doi: 10.1093/jac/dki205. Epub 2005 Jun 27.
8
Removal of therapeutic drugs by continuous arteriovenous hemofiltration.通过连续性动静脉血液滤过清除治疗药物。
Arch Intern Med. 1985 Sep;145(9):1651-2.
9
Removal of cephalosporins by continuous arteriovenous ultrafiltration (CAVU) and hemofiltration (CAVH).通过持续动静脉超滤(CAVU)和血液滤过(CAVH)清除头孢菌素。
Int J Artif Organs. 1989 Jun;12(6):379-83.
10
[Pharmacotherapy in severe liver failure].
Leber Magen Darm. 1982 Oct;12(5):188-92.

引用本文的文献

1
Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.持续肾脏替代治疗患者的药物剂量。药代动力学及治疗方面的考量。
Clin Pharmacokinet. 1993 May;24(5):362-79. doi: 10.2165/00003088-199324050-00002.